Comparison of Apathy and Cognitive Symptoms in Pre- and Postoperative Period in Deep Brain Stimulation Surgery

Overview

Journal Psychiatry Clin Psychopharmacol

Publisher Aves

Specialty Psychiatry

Date 2024 May 20

PMID 38765847

Authors

Selim Polat

Miray Erdem

Melih Cekinmez

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the study was to investigatie apathy and cognitive functions in Parkinson's disease patients who underwent deep brain stimulation surgery on bilateral subthalamic nuclei.

Methods: This study included 18 patients with Parkinson's disease who were accommodated in the Parkinson's and Movement Disorders Center of Adana City Training and Research Hospital for treatment in 2022. Patients were evaluated by psychiatry, neurology and neurosurgery specialists with a multidisciplinary approach and found to be surgically appropriate. Standardized Mini-Mental Test and Montreal Cognitive Assessment Scale, Apathy Evaluation Scale, and Hamilton Anxiety and Depression Scale were administered to each patient before the operation and at 6 months after effective stimulation parameters were reached.

Results: The mean apathy score at the preoperative zeroth month was 47.77 ± 15.83 in patients having deep brain stimulation surgery and 30.83 ± 13.59 in the postoperative sixth month. Statistically that reduction was significant ( = .003) and showed clinical development. The average Hamilton Anxiety Scale scores at the preoperative zeroth month was 11.50 ± 5.14 and 10.22 ± 5.57 at the postoperative sixth month, with no clinical significance ( = .280). The determined value for the Unified Parkinson's Disease Rating Scale, on treatment, was 22.55 ± 7.53 in the preoperative zeroth month and 14.50 ± 6.99 in the postoperative sixth month, with statistical significance (). The Unified Parkinson's Disease Rating Scale, off treatment, score was revealed to be significant in the preoperative zeroth month (37.44 ± 9.85) in comparison to that of the postoperative sixth month (23.44 ± 7.86; < .001).

Conclusion: This study showed that bilateral subthalamic stimulation improves nonmotor and motor symptoms in patients having Parkinson's disease. The mechanism is complex, and we believe that future studies focusing on pharmacological and nonpharmacological treatments involving more patient groups will be useful for clinicians.

Citing Articles

Cognitive aspects of motor control deteriorate while off treatment following subthalamic nucleus deep brain stimulation surgery in Parkinson's disease.

Munoz M, Arora R, Rivera Y, Drane Q, Pal G, Verhagen Metman L Front Neurol. 2025; 15:1463970.

PMID: 39744112 PMC: 11688652. DOI: 10.3389/fneur.2024.1463970.

Exploring the genetic and socioeconomic interplay between ADHD and anxiety disorders using Mendelian randomization.

Deng X, Ren H, Wu S, Jie H, Gu C Front Psychiatry. 2024; 15:1439474.

PMID: 39165506 PMC: 11333326. DOI: 10.3389/fpsyt.2024.1439474.

References

Bronstein J, Tagliati M, Alterman R, Lozano A, Volkmann J, Stefani A . Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2010; 68(2):165. PMC: 4523130. DOI: 10.1001/archneurol.2010.260. View

Lhommee E, Boyer F, Wack M, Pelissier P, Klinger H, Schmitt E . Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation. Mov Disord. 2017; 32(8):1191-1200. DOI: 10.1002/mds.27065. View

Krishnan S, Pisharady K, Divya K, Shetty K, Kishore A . Deep brain stimulation for movement disorders. Neurol India. 2018; 66(Supplement):S90-S101. DOI: 10.4103/0028-3886.226438. View

Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R . Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010; 9(6):581-91. PMC: 2874872. DOI: 10.1016/S1474-4422(10)70093-4. View

Mestre T, Espay A, Marras C, Eckman M, Pollak P, Lang A . Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. Mov Disord. 2014; 29(14):1751-6. DOI: 10.1002/mds.26024. View

Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K . A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006; 355(9):896-908. DOI: 10.1056/NEJMoa060281. View

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J . Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. Mov Disord. 2003; 18(5):524-30. DOI: 10.1002/mds.10441. View

Aarsland D, Bronnick K, Alves G, Tysnes O, Pedersen K, Ehrt U . The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry. 2009; 80(8):928-30. DOI: 10.1136/jnnp.2008.166959. View

Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello T . The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009; 24(11):1641-9. DOI: 10.1002/mds.22643. View

10.

Wichmann T, DeLong M . Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?. Neurotherapeutics. 2016; 13(2):264-83. PMC: 4824026. DOI: 10.1007/s13311-016-0426-6. View

11.

Erola T, Karinen P, Heikkinen E, Tuominen J, Haapaniemi T, Koivukangas J . Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients. Parkinsonism Relat Disord. 2005; 11(2):89-94. DOI: 10.1016/j.parkreldis.2004.08.006. View

12.

Kennedy S, Giacobbe P, Rizvi S, Placenza F, Nishikawa Y, Mayberg H . Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011; 168(5):502-10. DOI: 10.1176/appi.ajp.2010.10081187. View

13.

Fraix V, Houeto J, Lagrange C, Le Pen C, Krystkowiak P, Guehl D . Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006; 77(4):443-9. PMC: 2077508. DOI: 10.1136/jnnp.2005.077677. View

14.

Kwon K, Kang S, Kim M, Lee H, Jang J, Kim J . Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease. Can J Neurol Sci. 2014; 41(5):597-602. DOI: 10.1017/cjn.2014.3. View

15.

Schupbach W, Chastan N, Welter M, Houeto J, Mesnage V, Bonnet A . Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry. 2005; 76(12):1640-4. PMC: 1739461. DOI: 10.1136/jnnp.2005.063206. View

16.

Drapier D, Drapier S, Sauleau P, Haegelen C, Raoul S, Biseul I . Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?. J Neurol. 2006; 253(8):1083-91. DOI: 10.1007/s00415-006-0177-0. View

17.

Kirsch-Darrow L, Fernandez H, Fernandez H, Marsiske M, Okun M, Bowers D . Dissociating apathy and depression in Parkinson disease. Neurology. 2006; 67(1):33-8. PMC: 2911155. DOI: 10.1212/01.wnl.0000230572.07791.22. View

18.

Starkstein S, Ingram L, Garau M, Mizrahi R . On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry. 2005; 76(8):1070-4. PMC: 1739766. DOI: 10.1136/jnnp.2004.052795. View

19.

Halpern C, Rick J, Danish S, Grossman M, Baltuch G . Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease. Int J Geriatr Psychiatry. 2008; 24(5):443-51. DOI: 10.1002/gps.2149. View

20.

Chiken S, Nambu A . Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption?. Neuroscientist. 2015; 22(3):313-22. PMC: 4871171. DOI: 10.1177/1073858415581986. View